Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis
CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 23, 2026 /PRNewswire/ —…
STL completes successful trial of Multi-Core Fibre (MCF) with Colt in the UK, powering next-gen optical connectivity
LONDON, Jan. 22, 2026 /PRNewswire/ — STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure,…
Galopprennen: Kampf ums Diana-Ticket: Acht Stuten im Prüfstand.
Der Henkel-Preis der Diana am ersten August-Sonntag ist das Highlight der Grafenberger Galopprennsaison. 500.000 Euro gibt es zu…